home / stock / adk:cc / adk:cc quote
Last: | $0.22 |
---|---|
Change Percent: | 0.0% |
Open: | $0.22 |
Close: | $0.22 |
High: | $0.225 |
Low: | $0.22 |
Volume: | 18,502 |
Last Trade Date Time: | 05/06/2022 04:55:08 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.22 | $0.22 | $0.22 | $0.225 | $0.22 | 18,502 | 05-06-2022 |
$0.22 | $0.24 | $0.22 | $0.24 | $0.215 | 63,685 | 05-05-2022 |
$0.24 | $0.22 | $0.24 | $0.24 | $0.22 | 128,780 | 05-04-2022 |
$0.22 | $0.225 | $0.22 | $0.23 | $0.215 | 82,802 | 05-03-2022 |
$0.215 | $0.225 | $0.215 | $0.225 | $0.215 | 167,031 | 05-02-2022 |
$0.225 | $0.21 | $0.225 | $0.23 | $0.21 | 475,090 | 04-29-2022 |
$0.205 | $0.2 | $0.205 | $0.205 | $0.2 | 111,455 | 04-28-2022 |
$0.205 | $0.195 | $0.205 | $0.205 | $0.195 | 228,949 | 04-27-2022 |
$0.19 | $0.195 | $0.19 | $0.195 | $0.185 | 154,527 | 04-26-2022 |
$0.195 | $0.2 | $0.195 | $0.2 | $0.195 | 110,000 | 04-25-2022 |
$0.205 | $0.21 | $0.205 | $0.21 | $0.195 | 154,049 | 04-22-2022 |
$0.215 | $0.215 | $0.215 | $0.215 | $0.205 | 48,534 | 04-21-2022 |
$0.21 | $0.22 | $0.21 | $0.22 | $0.205 | 43,166 | 04-20-2022 |
$0.215 | $0.22 | $0.215 | $0.22 | $0.205 | 372,855 | 04-19-2022 |
$0.22 | $0.22 | $0.22 | $0.225 | $0.215 | 32,507 | 04-18-2022 |
$0.22 | $0.23 | $0.22 | $0.23 | $0.22 | 59,902 | 04-15-2022 |
$0.22 | $0.23 | $0.22 | $0.23 | $0.22 | 59,902 | 04-14-2022 |
$0.23 | $0.225 | $0.23 | $0.23 | $0.225 | 19,320 | 04-13-2022 |
$0.225 | $0.225 | $0.225 | $0.225 | $0.22 | 84,036 | 04-12-2022 |
$0.225 | $0.225 | $0.225 | $0.225 | $0.22 | 100,400 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Diagnos Inc. Company Name:
ADK:CC Stock Symbol:
TSXVC Market:
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie ...
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new H...
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research held April 10 th and April 11 th...